Nonpeptide 濞?sub>v閻?sub>3 Antagonists. Part 11: Discovery and Preclinical Evaluation of Potent 濞?sub>v閻?sub>3 Antagonists for the Prevention and Treatment of Osteoporosis was written by Coleman, Paul J.;Brashear, Karen M.;Askew, Ben C.;Hutchinson, John H.;McVean, Carol A.;Duong, Le T.;Feuston, Bradley P.;Fernandez-Metzler, Carmen;Gentile, Michael A.;Hartman, George D.;Kimmel, Donald B.;Leu, Chih-Tai;Lipfert, Lorraine;Merkle, Kara;Pennypacker, Brenda;Prueksaritanont, Thomayant;Rodan, Gideon A.;Wesolowski, Gregg A.;Rodan, Sevgi B.;Duggan, Mark E.. And the article was included in Journal of Medicinal Chemistry in 2004.Related Products of 90905-32-1 This article mentions the following:
3-(S)-Pyrimidin-5-yl-9-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-nonanoic acid (5e) and 3-(S)-(methylpyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-nonanoic acid (5f) were identified as potent and selective antagonists of the 濞?sub>v閻?sub>3 receptor. These compounds have excellent in vitro profiles (IC50 = 0.07 and 0.08 nM, resp.), significant unbound fractions in human plasma (6 and 4%), and good pharmacokinetics in rat, dog, and rhesus monkey. On the basis of the efficacy shown in an in vivo model of bone turnover following once-daily oral administration, these two compounds were selected for clin. development for the treatment of osteoporosis. In the experiment, the researchers used many compounds, for example, 2-Methoxypyrimidine-5-carbaldehyde (cas: 90905-32-1Related Products of 90905-32-1).
2-Methoxypyrimidine-5-carbaldehyde (cas: 90905-32-1) belongs to pyrimidine derivatives. The pyrimidine nitrogenous bases are derived from the organic compound pyrimidine through the addition of various functional groups. As nucleotides in DNA and RNA, pyrimidine nucleotide derivatives have a wide range of biological applications. For example, pyrimidine derivatives are useful in DNA repair studies involving cancer and epigenetics.Related Products of 90905-32-1
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia